Attenuation of lung injury in allograft rejection using NF-κB decoy transfection -: novel strategy for use in lung transplantation

被引:21
作者
Ohmori, K [1 ]
Takeda, S [1 ]
Miyoshi, S [1 ]
Minami, M [1 ]
Nakane, S [1 ]
Ohta, M [1 ]
Sawa, Y [1 ]
Matsuda, H [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Surg E1, Suita, Osaka 5650871, Japan
关键词
allograft lung injury; gene transfer; lung transplantation; NF-kappa B;
D O I
10.1016/j.ejcts.2004.09.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Increased production of nitric oxide (NO) is known to be a marker of lung allograft rejection and lung injury. NO production is up-regulated directly or indirectly by nuclear factor-kappa B (NF-kappaB), a transcriptional factor of inflammatory cytokines and iNOS. We attempted to determine whether transfection of an NF-kappaB decoy into allografts could reduce NO production and ameliorate acute lung injury during altograft rejection. Methods: Left lung transplantation was performed in pairs of Brown Norway (RT1(n)) and Lewis (RT1) rats. In Group NF (n = 6), the attografts were flushed with 20 ml of PBS solution containing a hemagglutinating virus of Japan (HVJ) tiposome-ODN complex as an NF-kappaB decoy and preserved for 60 min at 4 degreesC. A scramble decoy was used in the positive control (Group S, n = 5) and simple PBS solution in the negative control (Group C, n = 5). Five days after transplantation without use of immuno-suppressants, exhaled NO, gas exchange, and graft histological rejection score were determined. Results: The exhaled NO level was significantly reduced in Group NF as compared with Group S (445 +/- 162 vs 1305 +/- 123 ppb, P < 0.02), while improvements in PaO2 (197 +/- 28 vs. 60 +/- 18 mmHg, P < 0.02) and rejection score (1.8 +/- 0.3 vs. 2.5 +/- 0.4) were also observed. There were no differences in these parameters between Groups S and C. Conclusions: Inhibition of NF-kappaB activation in the altograft by ODN decoy transfection into the donor lung ameliorated lung injury during acute allograft rejection. Our results imply a possible therapeutic target for the inflammation process in lung transplantation clinical settings. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:23 / 27
页数:5
相关论文
共 25 条
[21]  
TRULOCK EP, 1997, AM J RESP CRIT CARE, V155, P769
[22]   Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart [J].
Ueda, H ;
Sawa, Y ;
Matsumoto, K ;
Kitagawa-Sakakida, S ;
Kawahira, Y ;
Nakamura, T ;
Kaneda, Y ;
Matsuda, H .
ANNALS OF THORACIC SURGERY, 1999, 67 (06) :1726-1731
[23]   Nitric oxide production by bronchoalveolar cells during allograft rejection in the rat [J].
Utsumi, T ;
Mizuta, T ;
Fujii, Y ;
Shiono, H ;
Okumura, M ;
Minami, M ;
Takeda, S ;
Miyoshi, S ;
Matsuda, H .
TRANSPLANTATION, 1999, 67 (12) :1622-1626
[24]   Ex vivo transfection of transforming growth factor-β1 gene to pulmonary artery segments in lung grafts [J].
Yano, M ;
Mora, BN ;
Ritter, JM ;
Scheule, RJ ;
Yew, NS ;
Mohanakumar, T ;
Patterson, GA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 117 (04) :705-712
[25]  
Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1